• About
    • Login
    View Item 
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    •   Institutional Repository Home
    • Electronic Theses and Dissertations
    • Electronic Theses and Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Institutional RepositoryCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsDepartmentThis CollectionBy Issue DateAuthorsTitlesSubjectsDepartment

    My Account

    LoginRegister

    Electronic Modification and Development of a More Reactive Chiral Proton Catalyst for the Enantioselective Aza-Henry Reaction and its Application to the Synthesis of Therapeutics

    Davis, Tyler Andrew
    : https://etd.library.vanderbilt.edu/etd-07222011-142610
    http://hdl.handle.net/1803/13442
    : 2011-08-04

    Abstract

    BisAMidine chiral proton catalysts are a class of mixed Brønsted acid/Brønsted base reagents amenable to both electronic and steric modification. A counterintuitive approach in which the creation of more Brønsted basic versions of these Brønsted acid catalysts led to more reactive catalysts (PBAM) that delivered highly diastereo- and enantioselective aza-Henry reactions. Factors that influence the reactivity of these catalysts have been uncovered. The development of these new catalysts has permitted the considerable expansion of the nitroalkane scope, including secondary nitroalkanes. Enantiomerically enriched compounds of medicinal importance are now easily accessible through this system. A potent GlyT1 inhibitor has been synthesized asymmetrically through an enantioselective aza-Henry reaction of a secondary nitroalkane and subsequent denitration. We also overcame the problems associated with the use of aryl nitromethane pronucleophiles in the aza-Henry reaction (low dr/ee), and have converted their addition products to the corresponding cis-imidazoline. This strategy has been successfully applied to the first enantioselective synthesis of (–)-Nutlin-3, a p53-MDM2 inhibitor currently in development by Hoffmann-La Roche. The synthesis of a library of new BAM ligands has been described. Furthermore, a large scale Organic Syntheses procedure for the synthesis of PBAM has been developed.
    Show full item record

    Files in this item

    Icon
    Name:
    Davis.pdf
    Size:
    14.79Mb
    Format:
    PDF
    View/Open

    This item appears in the following collection(s):

    • Electronic Theses and Dissertations

    Connect with Vanderbilt Libraries

    Your Vanderbilt

    • Alumni
    • Current Students
    • Faculty & Staff
    • International Students
    • Media
    • Parents & Family
    • Prospective Students
    • Researchers
    • Sports Fans
    • Visitors & Neighbors

    Support the Jean and Alexander Heard Libraries

    Support the Library...Give Now

    Gifts to the Libraries support the learning and research needs of the entire Vanderbilt community. Learn more about giving to the Libraries.

    Become a Friend of the Libraries

    Quick Links

    • Hours
    • About
    • Employment
    • Staff Directory
    • Accessibility Services
    • Contact
    • Vanderbilt Home
    • Privacy Policy